$9.25
-0.27-2.84%
Últ. Act.: Oct 30, 4:00 PM
DiaMedica Therapeutics (DMAC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.18 | $-0.18 | $-0.16 |
| Actual | $-0.19 | $-0.19 | $-0.17 | $-0.17 |
| Surprise | +5.00% | -5.56% | +5.56% | -6.25% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.21 | $-0.22 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.19 | $-0.20 | 5.00 % |
| Q1 | May 6, 2026 | $-0.19 | $-0.18 | -5.56 % |
| Q4 | Mar 30, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q3 | Nov 12, 2025 | $-0.17 | $-0.16 | -6.25 % |